Medtronic (MDT) Tops Q2 EPS by 22c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Medtronic Reports Second Quarter Fiscal 2021 Financial Results
November 24, 2020 6:45 AM EST- Q2 Revenue of $7.6 Billion Decreased 0.8% Reported and 1.5% Organic
- Q2 GAAP Diluted EPS of $0.36; Q2 Non-GAAP Diluted EPS of $1.02
DUBLIN, Nov. 24, 2020 /PRNewswire/ --Â Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2021, which ended October 30, 2020.
The company reported second quarter worldwide revenue of $7.647 billion, a decrease of 0.8 percent as reported and 1.5 percent on an organic basis, which adjusts for the $59 million benefit of foreign currency translation. Unless otherwise stated, all revenue growth rates in this press release... More
